Nebacumab

基本解释奈巴库单抗

网络释义

1)Nebacumab,奈巴库单抗2)Edobacomab,埃巴单抗3)Armyin Pane (1908~1970),巴奈,A.4)Basiliximab,巴利昔单抗5)scFv library,单链抗体库6)Bassnett,巴斯奈特

用法和例句

Application of basiliximab in prevention of acute allograft rejection in kidney transplantation recipients;

巴利昔单抗在预防肾移植后排斥反应中的应用

Influence of basiliximab and on recipients interleukin-2 and soluble interleukin-2 receptor after renal transplantation;

巴利昔单抗对肾移植受者白细胞介素2和可溶性白介素2受体的影响

Meta-analysis of the effect of basiliximab on renal graft rejection and survival

巴利昔单抗对肾移植排斥反应及移植物存活影响的Meta分析

Construction of a large human scFv library against SARS virus;

抗人SARS病毒单链抗体库的构建

Objective To obtain phage-displayed scFv library directly against breast cancer cells and select antibodies binding to breast cancer cells specifically so as to lay a foundation for developing diagnostic agents and clinical therapies of breast cancer.

3×106的单链抗体库。

Objective: To obtain phage-displayed ScFv library directly against prostate carcinoma cells, and select antibodies binding to prostate carcinoma cells specifically, so as to lay a foundation for developing diagnostic agents and clinical therapies of prostate carcinoma.

目的:获得前列腺癌的噬菌体呈现型单链抗体库,筛选与前列腺癌特异结合的抗体,为前列腺癌的诊断和治疗奠定基础。

On Chinese-English translation of Chinese neologisms from the perspective of Bassnett s cultural translation theory;

巴斯奈特的文化翻译观与汉语新词语英译

Manipulation and Construction: A Study of Susan Bassnett's "Cultural Translation" Theories

操纵与构建:苏珊·巴斯奈特“文化翻译”思想研究

In this paper the author explores Susan Bassnett s view on theatre translation.

本文梳理了巴斯奈特前后矛盾的戏剧翻译观。

Meta-analysis of the effect of basiliximab on renal graft rejection and survival

巴利昔单抗对肾移植排斥反应及移植物存活影响的Meta分析

The nursing experience of rituximab in combined with chemotherapy in elderly patient with non-hodgkin s lymphoma;

利妥昔单抗治疗老年非霍奇金淋巴瘤护理体会

Treatment of B-cell Lymphoma with the Regimen of Rituximab Combined Chemotherapy

利妥昔单抗联合化疗方案治疗B细胞淋巴瘤

Comparison of basilimab and antithymocyte globulin for clinical efficacy in early stage post renal transplantation

巴昔利单抗与抗胸腺细胞球蛋白在肾移植早期效果的比较

Systematic Review of Maintenance Rituximab Therapy in B Cell Non-Hodgkin Lymphoma

利妥昔单抗维持治疗B细胞非霍奇金淋巴瘤的系统评价

Clinic observation with diffuse large B-cell lymphoma treated by combination of rituximab and CHOP

利妥昔单抗联合CHOP方案治疗弥漫性大B细胞淋巴瘤临床观察

Clinical observation of effect of rituximab combined with chemotherapy on non-Hodgkin's lymphoma

利妥昔单抗联合化疗治疗非霍奇金淋巴瘤的临床观察

Clinical observation on rituximab combined with chemotherapy in the treatment of diffused large B cell lymphoma

利妥昔单抗联合化疗治疗弥漫型大B细胞淋巴瘤的临床观察

First biotechnology product approved by FDA to treat patients with cancer- a monoclonal antibody called rituximab, used to treat one type of lymphoma.

FDA批准首个治疗癌症的生物技术药物-一种称为利妥昔的单克隆抗体治疗一种淋巴瘤.

Rituximab combination with CHOP treated primary breast non-Hodgkin lymphoma:one case report and leterature review

利妥昔单抗联合CHOP方案治疗原发性乳腺非霍奇金淋巴瘤1例并文献复习

Nursing Care for Patients with B-Cell Non-Hodgkin's Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation Combined with Rituximab

2例B细胞非霍奇金淋巴瘤患者异基因造血干细胞移植联合利妥昔单抗治疗的护理

A Clinical Study of Rituximab Combined with CHOP in Treatment of B Cell Non-Hodgkins Lymphoma

利妥昔单抗联合CHOP治疗弥漫大B细胞性非霍奇金淋巴瘤的临床观察

The therapeutic effect observation and nursing for patients with rheumatic arthritis treated by infliximab

英芙利昔单抗治疗类风湿关节炎的疗效观察及护理

Efficacy of rituximab in patients with refractory severe systemic lupus erythematosus

利妥昔单抗治疗难治性重症系统性红斑狼疮的临床初步观察

Treatment of Immunorelated pancytopenia with regimen of rituximab and chemotherapy:a case report

利妥昔单抗联合化疗治疗免疫相关性全血细胞减少症1例

Rituximab therapy for rheumatoid arthritis

利妥昔单抗治疗类风湿性关节炎基础研究临床应用现状及展望

Use of Rituximab in Infant Childhood Immune Thrombocytopenic Purpura Who Useless with Routine Treatment

利妥昔单抗治疗婴幼儿常规治疗无效的特发性血小板减少性紫癜

Nursing care of a case of Crohn's disease treated by Infiximab

1例应用英夫利昔单抗治疗克罗恩病患者的护理

最新行业英语

词汇分类
高中词汇CET4词汇CET6词汇TOEFL词汇IELTS词汇GRE词汇考研词汇
首字母索引
ABCDEFGHIJKLMNOPQRSTUVWXYZ

本站部份资料来自网络或由网友提供,如有问题请速与我们联系,我们将立即处理!

Copyright © 2013-2024 杭州优配网络科技有限公司 All Rights Reserved 浙ICP备20019715号

免责声明:本站非营利性站点,以方便网友为主,仅供学习。合作/投诉联系QQ:1553292129